RICE HALL JAMES & ASSOCIATES, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$33,552,000
+83.7%
973,920
-10.9%
1.35%
+72.4%
Q2 2020$18,266,000
+28.9%
1,093,144
+11.3%
0.78%
-1.0%
Q1 2020$14,167,000
-41.7%
982,484
+35.4%
0.79%
-3.5%
Q4 2019$24,280,000
+54.1%
725,431
-3.6%
0.82%
+45.8%
Q3 2019$15,754,000
+13.0%
752,358
+12.4%
0.56%
+21.6%
Q2 2019$13,940,000
+22.1%
669,560
+31.1%
0.46%
+26.2%
Q1 2019$11,414,000510,7090.37%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders